Literature DB >> 22387483

Prevalence and predictors of slow flow in angiographically normal coronary arteries.

Yaron Arbel1, Efrat Rind, Shmuel Banai, Amir Halkin, Shlomo Berliner, Itzhak Herz, Noa Mashav, Tamar Thurm, Gad Keren, Ariel Finkelstein.   

Abstract

BACKGROUND: One out of 5 patients undergoing coronary angiography has angiographically normal coronary arteries (ANCA). Some of them have abnormally slow coronary flow (SCF). The prevalence and causes of SCF in these patients are not clear.
METHODS: We studied 114 consecutive patients with ANCA. Each angiogram was independently evaluated by 2 physicians unaware of all other clinical features of the case. Coronary flow (CF) was graded using the corrected TIMI Frame Count (cTFC) and Coronary Clearance Frame Count (CCFC) methodologies. SCF was defined as a cTFC exceeding the reported normal (mean cTFC + 2 SD) in each of the three major coronary arteries. The association between SCF and various clinical, inflammatory, and metabolic variables was tested using a multivariable analysis model.
RESULTS: Thirty-nine (34%) patients had SCF. Inter-individual CF varied substantially among them (range 10-143 frames/sec, mean: 37 ± 22 frames/sec). The intra-individual CF did not vary: CF correlated well in the three major epicardial coronary arteries of a given individual (r = 0.7, p = 0.0001). Multivariable analysis revealed that current smoking was the most significant variable related to SCF (odds ratio = 4.7, p = 0.006, CI 95% 1.6-13.3). The SCF group included significantly more smokers (41% versus 15%, p = 0.002).
CONCLUSIONS: SCF is a common finding (34%) among patients with angiographically normal coronary arteries. In these patients, slow flow is a systemic phenomenon that involves all three coronary arteries rather than a local event and is associated with current smoking.

Entities:  

Mesh:

Year:  2012        PMID: 22387483     DOI: 10.3233/CH-2012-1538

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  11 in total

1.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

2.  Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization.

Authors:  Yaron Arbel; Edo Y Birati; Ariel Finkelstein; Amir Halkin; Shlomo Berliner; Ben-Zion Katz; Miri Revivo; Hila Saranga; Itzhak Herz; Gad Keren; Shmuel Banai
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

3.  Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.

Authors:  Yaron Arbel; Shani Shenhar-Tsarfaty; Nir Waiskopf; Ariel Finkelstein; Amir Halkin; Miri Revivo; Shlomo Berliner; Itzhak Herz; Itzhak Shapira; Gad Keren; Hermona Soreq; Shmuel Banai
Journal:  Mol Med       Date:  2014-02-12       Impact factor: 6.354

4.  Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity.

Authors:  E Melles; H Jörnvall; S Tryggvason; K Gemzell Danielsson; K Ekberg; K Tryggvason; J Wahren; T Bergman
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

5.  Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.

Authors:  Yaron Arbel; Margalit Zlotnik; Amir Halkin; Ofer Havakuk; Shlomo Berliner; Itzhak Herz; Itay Rabinovich; Gad Keren; Shmuel Bazan; Ariel Finkelstein; Shmuel Banai
Journal:  Clin Res Cardiol       Date:  2013-11-24       Impact factor: 5.460

6.  Coronary Slow Flow Phenomenon Clinical Findings and Predictors.

Authors:  Hamidreza Sanati; Reza Kiani; Farshad Shakerian; Ata Firouzi; Ali Zahedmehr; Mohammadmehdi Peighambari; Leila Shokrian; Peiman Ashrafi
Journal:  Res Cardiovasc Med       Date:  2016-01-02

7.  Prevalence and predictors of slow coronary flow phenomenon in Kermanshah province.

Authors:  Mohammad Rouzbahani; Saeid Farajolahi; Nafiseh Montazeri; Parisa Janjani; Nahid Salehi; Alireza Rai; Reza Heidari Moghadam; Arsalan Naderipour; Asal Kanjorpor; Etrat Javadirad; Javad Azimivghar
Journal:  J Cardiovasc Thorac Res       Date:  2021-01-13

8.  Plasma atherogenic indices are independent predictors of slow coronary flow.

Authors:  Abdulmecit Afsin; Hakan Kaya; Arif Suner; Kader Eliz Uzel; Nurbanu Bursa; Yusuf Hosoglu; Fethi Yavuz; Ramazan Asoglu
Journal:  BMC Cardiovasc Disord       Date:  2021-12-20       Impact factor: 2.298

9.  Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.

Authors:  Saibal Mukhopadhyay; Mitesh Kumar; Jamal Yusuf; Vinod Kumar Gupta; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2017-09-04

10.  Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.

Authors:  Yao-Dong Ding; Yu-Qiang Pei; Rui Wang; Jia-Xing Yang; Yin-Xin Zhao; Xiao-Li Liu; Hua Shen; Qian Ma; Shuo Zhang; Hai-Long Ge
Journal:  BMC Cardiovasc Disord       Date:  2020-05-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.